The digital immunoassays market is projected to grow from USD 2.4 billion in 2026 to USD 7.1 billion by 2036, at a CAGR of 11.4%. Protein biomarker assays will dominate with a 44.0% market share, while hospital and clinical laboratories will lead the end‑user segment with a 42.0% share.